Related Articles
Inhibition of IGFBP-2 improves the sensitivity of bladder cancer cells to cisplatin via upregulating the expression of maspin
Inhibiting the cytoplasmic location of HMGB1 reverses cisplatin resistance in human cervical cancer cells
Oblongifolin C reverses GEM resistance via suppressing autophagy flux in bladder cancer cells
Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways
Cisplatin resistance by induction of aldo‑keto reductase family 1 member C2 in human bladder cancer cells